InVivo Therapeutics Holdings Corp. announced the appointment of Richard Christopher as its Chief Financial Officer and Treasurer, effective January 14, 2019. Prior to joining the company, Mr. Christopher was the Chief Financial Officer of iCAD Inc. Mr. Christopher was Chief Financial Officer and Chief Operating Officer of Caliber Imaging & Diagnostics Inc.
InVivo Therapeutics Holdings Corp.
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3942 USD | +2.31% | +6.54% | -46.00% |
04-16 | North American Morning Briefing : Powell Comments, -2- | DJ |
04-02 | North American Morning Briefing : Stocks Seen -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-46.00% | 1.2M | |
+11.10% | 226B | |
+14.92% | 198B | |
+19.76% | 142B | |
+30.08% | 111B | |
+2.09% | 65.26B | |
+15.53% | 54.36B | |
+6.68% | 50.94B | |
+9.34% | 44.8B | |
+4.26% | 36.8B |
- Stock Market
- Equities
- NVIV Stock
- News InVivo Therapeutics Holdings Corp.
- InVivo Therapeutics Holdings Corp. Announces the Appointment of Richard Christopher as Chief Financial Officer and Treasurer